CONSULTING AGREEMENTConsulting Agreement • July 19th, 2022 • RenovoRx, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 19th, 2022 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is made as of April 25, 2022 (the “Effective Date”), by and between RenovoRx, Inc., a Delaware corporation, with its principal place of business being 4546 El Camino Real, Suite B1, Los Altos, CA 94022 (the “Company”) and Danforth Advisors, LLC, a Massachusetts limited liability company, with its principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”). The Company and Danforth are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”